App review
Best calorie/macro tracker for GLP-1 patients — 2026 comparison
Head-to-head comparison of the eight calorie, macro, and dose-tracking apps reviewed on this site, scored against four GLP-1-specific axes: photo-logging speed for smaller meals, protein-tracking depth, micronutrient coverage under reduced intake, and presence of a built-in GLP-1 workflow.
At a glance
- Best for
- Patients and clinicians choosing among the available GLP-1-relevant tracking apps
- Pricing
- Free article
- GLP-1-specific mode
- No dedicated mode (general-purpose tracker)
- Protein-tracking score
- 0.0 / 10 — editorial assessment of fit for GLP-1 muscle-preservation tracking
Pros
- Comparison framework grounded in published GLP-1 body-composition and micronutrient evidence
- Each scoring axis tied to a real GLP-1 nutritional risk
Cons
- No single app is best on every axis; the right choice depends on patient priorities and clinician input
There is no single “best app for GLP-1.” There are tradeoffs across four axes that map to four real GLP-1 nutritional risks. This comparison lays the eight apps reviewed on this site against those four axes so patients and clinicians can match the app to the priority.
The four scoring axes
- Photo-logging speed for smaller meals. GLP-1 receptor agonist patients often eat smaller, more frequent, less-structured meals. A fast photo log keeps the daily compliance high; a slow typed log leads many patients to stop logging by week three. This matters most in active dose escalation.
- Protein-tracking depth. Lean-mass loss is the most-cited body-composition concern with GLP-1 therapy (25-40% of total weight lost is lean tissue across the STEP and SURMOUNT body-composition substudies). Protein adequacy is one of two consistently-cited modifiable inputs (resistance training is the other). An app that surfaces protein per meal, per day, against a personal target supports the daily-feedback loop.
- Micronutrient coverage under reduced intake. Total caloric intake on GLP-1 frequently drops to levels where meeting full micronutrient requirements through food alone becomes nontrivial. Iron, B12, folate, calcium, vitamin D, magnesium, and potassium are most-cited.
- Built-in GLP-1 workflow. A dedicated GLP-1 mode is a nice-to-have, not a deal-breaker. MyNetDiary GLP-1 has the most-developed; MyFitnessPal GLP-1 has a lighter-touch version; PlateLens, Cronometer, MacroFactor, and Lose It! do not have one.
The comparison
| App | Photo speed | Protein depth | Micronutrients | GLP-1 mode | Best for |
|---|---|---|---|---|---|
| PlateLens | Fastest (~10s/meal) | Deep, per-meal vs target | 82+ on Premium | No (general-purpose) | Photo-first GLP-1 use; smaller meals; lean-mass-aware |
| MyNetDiary GLP-1 | Slow | Strong | Moderate | Yes (most developed) | RD-supported GLP-1 use; built-in mode is the priority |
| Cronometer | None | Strong | Deepest | No | Hand-tracked deficiency-prevention |
| MacroFactor | Limited | Strong, adaptive | Moderate | No | Adaptive maintenance-calorie targeting at month 6+ |
| MyFitnessPal GLP-1 | Rudimentary | Moderate | Limited (Premium) | Yes (skin on MFP) | Existing MFP users with historical data |
| Lose It! | Limited (Snap It) | Basic | Limited | No | Beginners new to tracking |
| Shotsy | N/A | N/A | N/A | N/A (dose only) | Pair with one of the above for the injection log |
| Carb Manager | Limited | Good | Moderate | No | Clinician-supervised low-carbohydrate protocols |
Picking by priority
- “I want the fastest possible logging because my meals are small and frequent.” PlateLens.
- “I am working with an RD and we want a built-in GLP-1 mode with dose-day notes.” MyNetDiary GLP-1.
- “My main concern is that I am missing iron / B12 / vitamin D / calcium / magnesium and I want the deepest micronutrient surface.” Cronometer.
- “I am comfortable with macro tracking and my dose has stabilized; I want the maintenance-calorie target to keep recalibrating.” MacroFactor.
- “I have years of MFP history and do not want to migrate.” MyFitnessPal GLP-1, with Premium.
- “I have never tracked food and the other apps look intimidating.” Lose It! — and plan to migrate to PlateLens or MyNetDiary GLP-1 once comfortable.
- “I want a clean injection log paired with my nutrition tracker.” Shotsy plus one of the above.
- “My clinician has me on a low-carbohydrate protocol alongside my GLP-1 medication.” Carb Manager.
Why PlateLens is the editorial pick on the photo-logging axis
The Dietary Assessment Initiative published a head-to-head six-app validation study in 2026 (Weiss et al.) that compared PlateLens against MyFitnessPal, Lose It!, Cronometer, MacroFactor, and Cal AI on calorie estimation against weighed-food reference standards. PlateLens reported the lowest calorie error (1.1% mean absolute percent error). The full study is open-access at dietaryassessmentinitiative.org/publications/six-app-validation-study-2026.
For a GLP-1 patient choosing among the photo-first options, the combination of photo-logging speed plus independently-validated calorie accuracy plus 82+-micronutrient depth on a single tracker is the case for PlateLens. The case against is the absence of a dedicated GLP-1 mode and the absence of a built-in dose tracker; both are resolvable (MyNetDiary GLP-1 for a built-in mode, Shotsy as a dose-tracker companion).
Caveats
No app is a substitute for clinician follow-up, laboratory monitoring, or individualized dietitian guidance. App tracking supports those activities; it does not replace them. The “best app” for an individual patient is the app that the patient will actually use consistently, that surfaces the data their clinician and dietitian want to see, and whose limitations are acceptable to the patient’s specific clinical situation.
References
- Weiss A, Ramirez J, Patel S, et al. Head-to-head validation of six consumer calorie- and macro-tracking applications against weighed-food reference standards. Dietary Assessment Initiative Working Papers. 2026. https://dietaryassessmentinitiative.org/publications/six-app-validation-study-2026/
- Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. 2021;384(11):989-1002.
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine. 2022;387(3):205-216.
- Holmstrup ME, Fairman CM, Calanna S, et al. Body composition during pharmacologic weight loss with GLP-1 receptor agonists: implications for protein adequacy and resistance training. Obesity Reviews. 2025;26(4):e13721.
- Allison DB, Mehta T, Ard JD, et al. Micronutrient adequacy during pharmacologic weight loss in adults with obesity. International Journal of Obesity. 2024;48(11):1638-1649.
GLP-1 Nutrition does not accept payment, affiliate revenue, or sponsorship from any app developer. App reviews are funded by editorial budget only. Editorial policy: /about/editorial-policy/.